Tumor Samples Harboring Novel Stem Cell Factor FOXD3 Variants

Tumor Samples Harboring Novel Stem Cell Factor FOXD3 Variants

  2. Technologies
  3. Tumor Samples Harboring Novel Stem Cell Factor FOXD3 Variants
  4. Summary
Provided by: National Institutes of Health (NIH)
Tags: anti-cancer cancer Breast Cancer GPCR Cell Line
Short Description:

This technology pertains to patient-derived gastrointestinal tumors (GIST) and paraganglioma tumors that harbor genetic mutations that have an effect on early stage embryogenesis.

Projects based on this Technology

Start New Project